Instruction Source: P04.13
Newborn affected by maternal use of anticonvulsants
Instruction Source: P04.1
Newborn affected by other maternal medication
Excludes 1 (Mutually Exclusive)
- dysmorphism due to warfarin (Q86.2)
- fetal hydantoin syndrome (Q86.1)
Excludes 2 (Not Included Here)
- maternal anesthesia and analgesia in pregnancy, labor and delivery (P04.0)
- maternal use of drugs of addiction (P04.4-)
Instruction Source: P04
Newborn affected by noxious substances transmitted via placenta or breast milk
Excludes 2 (Not Included Here)
- congenital malformations (Q00-Q99)
- encounter for observation of newborn for suspected diseases and conditions ruled out (Z05.-)
- neonatal jaundice from excessive hemolysis due to drugs or toxins transmitted from mother (P58.4)
- newborn in contact with and (suspected) exposures hazardous to health not transmitted via placenta or breast milk (Z77.-)
Inclusion Terms
- nonteratogenic effects of substances transmitted via placenta
Instruction Source: P00-P04
Newborn affected by maternal factors and by complications of pregnancy, labor, and delivery (P00-P04)
Clinical Notes
- These codes are for use when the listed maternal conditions are specified as the cause of confirmed morbidity or potential morbidity which have their origin in the perinatal period (before birth through the first 28 days after birth).
Instruction Source: P00-P96
Certain conditions originating in the perinatal period
Excludes 2 (Not Included Here)
- congenital malformations, deformations and chromosomal abnormalities (Q00-Q99)
- endocrine, nutritional and metabolic diseases (E00-E88)
- injury, poisoning and certain other consequences of external causes (S00-T88)
- neoplasms (C00-D49)
- tetanus neonatorum (A33)
Inclusion Terms
- conditions that have their origin in the fetal or perinatal period (before birth through the first 28 days after birth) even if morbidity occurs later
Clinical Notes
- Codes from this chapter are for use on newborn records only, never on maternal records